MTP-219

N/A

Report date: 2026/01/21 20:00:47
NME

Base Information

Drug NameMTP-219
Drug Alias NameMTP-219 (Molecular Theranostics)PET imaging agent (Molecular Theranostics)PET probe-Ga-68 chelate (Molecular Theranostics)Gallium [Ga68] -MTP220MTP-219 +[6] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMolecular Theranostics LLC
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospitals Seidman Cancer CenterMolecular Theranostics LLCCase Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsSolid tumoursHead and Neck NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A